Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Specific Protein Target QSAR Modeling Using ChEMBL

Abstract The proprietary nature of AI/ML tools in drug discovery limits access to advanced virtual screening methodologies. To address this, we present an open-source, automated pipeline for large-scale Quantitative Structure−Activity Relationship (QSAR) modeling utilizing ChEMBL. Our batch processing system constructed 2263 predictive models across multiple protein targets, applying both regression and classification strategies with strict quality control thresholds. The pipeline integrates ErG and RDKit descriptor families, employs Random Forest and XGBoost algorithms with Optuna-based hyperparameter optimization, and handles class imbalances using SMOTE. Models are saved only when achieving R2 ≥ 0.7 for regression or MCC ≥ 0.55 for classification. Data is stratified by assay and measurement types to maintain biological relevance. Additionally, we feature an interactive EDA visualization tool with ErG heatmaps and external validation via the DELTA database. This work democratizes industrial-grade QSAR infrastructure, empowering the research community to reproduce and extend computational workflows.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-10-29
DOI
https://doi.org/10.1021/acs.jmedchem.6c00791
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Specific Protein Target QSAR Modeling Using ChEMBL

Alessandro Pedretti, Andrea Zaliani, Giulio Vistoli, Arianna Pisati et al.
2 links
Journal of Medicinal Chemistry
Computational Drug Discovery Methods
article

Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Specific Protein Target QSAR Modeling Using ChEMBL

Alessandro Pedretti, Andrea Zaliani, Giulio Vistoli, Arianna Pisati, Agnese Pozzi
article en

Abstract

Abstract The proprietary nature of AI/ML tools in drug discovery limits access to advanced virtual screening methodologies. To address this, we present an open-source, automated pipeline for large-scale Quantitative Structure−Activity Relationship (QSAR) modeling utilizing ChEMBL. Our batch processing system constructed 2263 predictive models across multiple protein targets, applying both regression and classification strategies with strict quality control thresholds. The pipeline integrates ErG and RDKit descriptor families, employs Random Forest and XGBoost algorithms with Optuna-based hyperparameter optimization, and handles class imbalances using SMOTE. Models are saved only when achieving R2 ≥ 0.7 for regression or MCC ≥ 0.55 for classification. Data is stratified by assay and measurement types to maintain biological relevance. Additionally, we feature an interactive EDA visualization tool with ErG heatmaps and external validation via the DELTA database. This work democratizes industrial-grade QSAR infrastructure, empowering the research community to reproduce and extend computational workflows.

Journal of Medicinal Chemistry
University of Milan (IT)
European Union Studies Association
Good health and well-being
Openalex Percentile: Top 14%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Specific Protein Target QSAR Modeling Using ChEMBL — Alessandro Pedretti, Andrea Zaliani, et al. · Journal of Medicinal Chemistry (2026) | TGRS Research Map | TGRS